Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow-up strategies
{{output}}
Glioblastoma (GBM) is a highly malignant brain tumor with a poor survival prognosis of 12-15 months despite current therapeutic strategies. Diagnosing GBM is challenging, often requiring invasive techniques such as tissue biopsy and imaging methods that can pr... ...
